Company Research
Click to download our company report on
Peptech (PTDX.L) - transition offers potential for greater shareholder value

(52 pages, this is a 985k download)

Click to download our company report on
London Capital (LCG.L) - concentration on tight spreads powers growth

(32 pages, this is a 398k download)

Click to download our company report on
Immersion Technologies (ITI.L) - sounds rewarding!

(28 pages, this is a 691k download)

Click to download our company report on
Peat Resources (PET.V) - developing Canada's peat resources, equivalent to 26bn tonnes of coal

(24 pages, this is a 684k download)

Click to download our company report on
Gold Summit (GSM.V) - early stage explorer with a portfolio of epithermal, bonanza-drill targets in Nevada

(40 pages, this is a 871k download)

Click to download our company report on
GLR Resources (GRS.TO) - an advanced-stage deposit with the potential for for quick development and strong cash flows

(32 pages, this is a 874k download)

Click to download our company report on
Macau Property Opportunities (MPO.L) - burgeoning casino revenues are driving a regeneration of the Macau property sector

(44 pages, this is a 1M download)

Click to download our company report on
FirstGrowth Capital (FGC.V) - technology is changing the economics of seismic services

(32 pages, this is a 629k download)

Click to download our company report on
Tinci Holdings (TNCI.L) - Chinese environmental engineering firm oversold on 2006 profit warning

(40 pages, this is a 780k download)

Click to download our company report on
First Artist (FAN.L) - Dewynters acquisition reduces reliance on football

(36 pages, this is a 990k download)

Click to download our company report on
CardioVascular BioTherapeuticsm Inc (CVBT.OB) - Angiogenesis: The Comeback Kid?

(48 pages, this is a 780k download)

Click to download our company report on
York Pharma (YRK.L) - a second shot at the Big Prize

(44 pages, this is a 1M download)

Click to download our company report on
Alliance Pharma (APH.L) - a speciality pharma business, LBO style

(40 pages, this is a 1.9M download)

Click to download our company report on
Great Panther Resources (GPR.V) - a future top 5 primary silver producer

(40 pages, this is a 991k download)

Click to download our company report on
SubSea Resources (SUB.L) - turning ripping yarns into a disciplined business

(32 pages, this is a 850k download)

Click to download our company report on
CeNeS Pharmaceuticals (CEN.L) - a pivotal year, failure would be very surprising indeed!

(44 pages, this is a 1.1M download)

Click to download our company report on
Taghmen Energy (TAG.L) - transition to a producer

(40 pages, this is a 1.6M download)

Click to download our company report on
Elixir Petroleum (ELP.L) - has the market over reacted?

(32 pages, this is a 980k download)

Click to download our company report on
Macro 4 (MAO.L) - growth tiger or cash cow?

(24 pages, this is a 340k download)

Click to download our company report on
Medsea Estates (MEA.L) - the serious business of homes in the sun

(28 pages, this is a 812k download)

Click to download our company report on
China Diamond (CDC.V) - opportunity at China's only producing diamond mine

(32 pages, this is a 1.7M download)

Click to download our company report on
Cardinal Resources (CDL.L) - a story of Ukrainian reform and high energy prices

(28 pages, this is a 700k download)

Click to download our company report on
Peat Resources (PET) - more than a commodity cycle play

Click to download our report on their industry
The Peat Industry - alternative energy out of the bog

Previous Themed research
Click to download our report on
The changing face of UK broadcast entertainment

Click to download our report on
Riding the UK's China dragons

Click to download our report on
How to play the alternative energy sector

Previous issues of the Small and Mid-Cap Review
July 2006
June 2006
April 2006
January 2006
November 2005
October 2005
September 2005
August 2005
June 2005
April 2005
April 2005
February 2005
January 2005
November 2004
October 2004
Our first issue

 
Disclaimer

Objective Capital is a provider of corporate research. Our research reports provide information, analysis, and estimates and may reference our opinion on the value of highlighted companies. Objective Capital is not registered by any financial authority, and does not provide or purport to provide investment advice or recommendations of any description.

The information in this report is designed to present the opinion of Objective's analysts and what they believe to be the objective prospects of the highlighted company. Where reference is made to estimates of value or relative value of a specific company these are based on standard analysis assuming an "average" investor. There is no guarantee that these estimates are reliable or will eventuate. They should not be relied upon in forming specific investment decisions and readers should seek advice specific to their situation and investment requirements from a person authorized under the Financial Services and Markets Act 2000, before entering into any investment agreement.

Objective Capital's detailed reports are only available to ordinary business investors, market counterparties, high net-worth and sophisticated individual investors.

This report does not constitute an offer or invitation to purchase or acquire any shares in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares in any company.

The information in this report is believed to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise.

Objective Capital (including its Directors, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules. Objective Capital and its analysts are bared from trading in the shares of companies on which Objective Capital provides coverage.

You are reminded that the value of shares in any company may go up or down. Past performance is not necessarily a guide to future performance.